Pharmaceutical price regulation national policies versus global interests
Increasing global regulation of drug prices and expenditures already affects the efficiency of pharmaceutical R&D and of health care delivery, with important implications for patient care now and in the future. The author examines the effect of existing foreign regulation - price controls, rate-...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | UnknownFormat |
| Sprache: | eng |
| Veröffentlicht: |
Washington, D.C.
AEI Press
1997
|
| Schlagworte: |
Drogues - Prix - États-Unis
> Farmaceutische industrie
> Geneesmiddelen
> Industrie pharmacautique - Etats-Unis
> Industrie pharmaceutique - Etats-Unis
> Industrie pharmaceutique - États-Unis
> Médicaments - Politique gouvernementale - États-Unis
> Médicaments - Prix - Etats-Unis
> Médicaments - Prix - États-Unis
> Politique pharmaceutique - États-Unis
> Prijsbeleid
> Cost Control
> Drug Costs
> Drugs
> Prices
> Economics, Pharmaceutical
> Pharmaceutical industry
> Pharmaceutical policy
> Public Policy
> Arzneimittelmarkt
> Gesundheitspolitik
> Preisregelung
> Arzneimittelpreis
> USA
> Preisregulierung
|
| Online Zugang: | Inhaltsverzeichnis |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Tag hinzufügen | Zusammenfassung: | Increasing global regulation of drug prices and expenditures already affects the efficiency of pharmaceutical R&D and of health care delivery, with important implications for patient care now and in the future. The author examines the effect of existing foreign regulation - price controls, rate-of-return regulations, and industrial policies - on U.S. and other multinational producers of innovative drugs. She explores the growing threat to global revenues from the regulatory use of international price comparisons and the increasing threat from parallel trade. |
|---|---|
| Beschreibung: | VII, 107 S. graph. Darst. |
| ISBN: | 0844739820 0-8447-3982-0 0844739839 0-8447-3983-9 |